January 30, 2019
Pivotal Phase 2b/3 ALVAC/Bivalent gp120/MF59 HIV Vaccine Prevention Safety and Efficacy Study in South Africa
Read More
December 10, 2018
Safety and Immune Response to a Clade C DNA HIV Vaccine
Read More
X